Molecular Mechanisms of Sensorineural Hearing Loss and Development of Inner Ear Therapeutics |
Autore | Vlajkovic Srdjan M |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (5793 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
brain-derived neurotrophic factor
TrkB inner ear development zebrafish mitochondria dysfunction reactive oxygen species hypoxic d-galactose high-fat diet aging hearing loss astrocytes auditory brainstem lateral superior olive gap junctions voltage-activated calcium channel 1.3 otoferlin spontaneous activity deafness circadian dysregulation clock genes noise-induced hearing loss sensory hair cells synaptic ribbons sensorineural hearing loss hyperbaric oxygenation adjunctive therapy microRNAs cochlear nucleus inferior colliculus neuroplasticity noise-induced cochlear injury cochlear rescue otoprotection adenosine A1 receptor regulator of G protein signalling 4 CCG-4986 intratympanic drug delivery potassium voltage-gated channel subfamily q member 4 potassium nonsyndromic hearing loss KCNQ4 activator age-related hearing loss selegiline chronic oral treatment hearing protection mouse model |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557463003321 |
Vlajkovic Srdjan M | ||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Understanding Neuromuscular Health and Disease: Advances in Genetics, Omics, and Molecular Function |
Autore | Duddy William |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (318 p.) |
Soggetto topico | Research & information: general |
Soggetto non controllato |
LMNA
Emery-Dreifuss muscular dystrophy Omics ALS MND ALS variants genotype-phenotype ALS genes FSHD DUX4 transcription muscle regulation spinal muscular atrophy adult patients disease heterogeneity Nusinersen disease modifiers functional outcomes biomarkers epigenetic changes -omics approaches oxidative stress mitochondria dysfunction axonal transport autophagy endocytosis secretion excitotoxicity RNA metabolism Duchenne muscular dystrophy (DMD) exon-skipping therapies next-generation sequencing (NGS) Sanger sequencing multiplex ligation probe amplification (MLPA) multiplex polymerase chain reaction (PCR) comparative genomic hybridization array (CGH) viltolarsen eteplirsen golodirsen rheumatoid arthritis SNP DMARD methotrexate pharmacogenomics Duchenne muscular dystrophy pharmacodynamic biomarkers prednisone deflazacort glucocorticoids corticosteroids safety neuromuscular diseases translational research disease models precision medicine miRNA proteomics calprotectin dystrophy Becker muscular dystrophy dystrophinopathy genotype-phenotype correlations Canadian Neuromuscular Disease Registry reading frame rule dystrophin multiple logistic regression analysis exon skipping therapy Amyotrophic Lateral Sclerosis machine learning genome-wide association studies GWAS genomics ALS pathology gene prioritization AAV genetic neuromuscular disorders gene therapy clinical trials toxicity SMA DMD XLMTM facioscapulohumeral dystrophy TALEN CRISPR-Cas9 gene editing polyadenylation D4Z4 duchenne muscular dystrophy (DMD) becker muscular dystrophy (BMD) exon skipping skip-equivalent deletions |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Understanding Neuromuscular Health and Disease |
Record Nr. | UNINA-9910557669103321 |
Duddy William | ||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|